QUICK SEARCH:   [advanced] Author: Keyword(s):
Home     Help     Feedback     Subscriptions     Archive     Search     Table of Contents

First published online 15 March 2005
doi: 10.1242/jcs.01717

This Article Figures Only Full Text Full Text (PDF) All Versions of this Article: jcs.01717v1 118/7/1405    most recent Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JCS Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Griffin, M. A. Articles by Discher, D. E. Search for Related Content PubMed PubMed Citation Articles by Griffin, M. A. Articles by Discher, D. E.

-Sarcoglycan deficiency increases cell contractility, apoptosis and MAPK pathway activation but does not affect adhesion

¹ Pennsylvania Muscle Institute, University of Pennsylvania Medical Center, D-700 Richards Building, 3700 Hamilton Walk, Philadelphia, PA 19104-6083, USA
² Department of Chemical and Biomolecular Engineering, Towne Building, 220 South 33rd Street, University of Pennsylvania, Philadelphia, PA 19104-6393, USA
³ Department of Physiology, University of Pennsylvania Medical Center, 3700 Hamilton Walk, Philadelphia, PA 19104-6085, USA
⁴ Graduate Group in Cell and Molecular Biology, University of Pennsylvania Medical Center, 3620 Hamilton Walk, Philadelphia, PA 19104-6058, USA

^* Author for correspondence (e-mail: discher{at}seas.upenn.edu)

Accepted 10 January 2005

The functions of -sarcoglycan (SG) in normal myotubes are largely unknown, however SG is known to assemble into a key membrane complex with dystroglycan and its deficiency is one known cause of limb-girdle muscular dystrophy. Previous findings of apoptosis from SG-deficient mice are extended here to cell culture where apoptosis is seen to increase more than tenfold in SG-deficient myotubes compared with normal cells. The deficient myotubes also exhibit an increased contractile prestress that results in greater shortening and widening when the cells are either lightly detached or self-detached. However, micropipette-forced peeling of single myotubes revealed no significant difference in cell adhesion. Consistent with a more contractile phenotype, acto-myosin striations were more prominent in SG-deficient myotubes than in normal cells. An initial phosphoscreen of more than 12 signaling proteins revealed a number of differences between normal and SG^–/– muscle, both before and after stretching. MAPK-pathway proteins displayed the largest changes in activation, although significant phosphorylation also appeared for other proteins linked to hypertension. We conclude that SG normally moderates contractile prestress in skeletal muscle, and we propose a role for SG in membrane-based signaling of the effects of prestress and sarcomerogenesis.

Key words: Sarcoglycan, Muscular dystrophy, Limb-girdle muscular dystrophy, Differentiation

Related articles in JCS:

A signalling role for -sarcoglycan

JCS 2005 118: 702. [Full Text]  

This article has been cited by other articles:

				E. R. Barton Impact of sarcoglycan complex on mechanical signal transduction in murine skeletal muscle Am J Physiol Cell Physiol, February 1, 2006; 290(2): C411 - C419. [Abstract] [Full Text] [PDF]

				D. E. Discher, P. Janmey, and Y.-l. Wang Tissue Cells Feel and Respond to the Stiffness of Their Substrate Science, November 18, 2005; 310(5751): 1139 - 1143. [Abstract] [Full Text] [PDF]